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Drug abuse researchers and service providers have markedly
different professional vocabularies and points of view. To
cite just a few examples: Researchers focus on outcomes,
while treatment providers promote recovery; clinicians
work one-on-one to make a difference for individual patients,
while researchers tend to compare the experiences of
groups, looking for widely applicable insights into drug
abuse and its treatment; the time frame in the clinic is
as immediate as human emotion or personal emergency,
while research—of necessity—moves painstakingly toward
the goal of advancing human understanding to realize
future improvements.
Despite their different perspectives, what unites drug
abuse researchers and practitioners is much stronger than
what separates them. In NIDA’s National Drug Abuse
Treatment Clinical Trials Network (CTN), we have clearly
seen that scientists and practitioners are eager and able
to combine their efforts to achieve the common goal of
reducing drug abuse and the damage it wreaks. Although
CTN is only 2 years old, its membership already includes
14 regional research centers and 93 community treatment
programs. Scientists and treatment providers have agreed
upon 12 specific research concepts and worked together
to design 7 trial protocols that meet clinics’ need for eco-
nomical operations and researchers’ needs for rigorous
data.
Rich interprofessional exchanges and collaborations,
such as those taking place in CTN and elsewhere, are
essential to improving the effectiveness of drug abuse
treatment and prevention to the greatest degree and at
the most rapid pace. Toward that end, Science & Practice
Perspectives will play an important role by helping scien-
tists and service providers share information and provide
mutual inspiration.
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